menu
    • menu

    Company profile for AOP Orphan

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.As a European pioneer in the treatment of rare diseases, AOP Orphan is active in all five continents with its several years of expertise. Since the very start the company has been focused on the individual needs and treatments of ...
    We at AOP Orphan are European pioneers in the field of rare diseases, researching, developing, producing, and distributing innovative solutions worldwide since 1996. Learn more about the company here.As a European pioneer in the treatment of rare diseases, AOP Orphan is active in all five continents with its several years of expertise. Since the very start the company has been focused on the individual needs and treatments of patients with rare diseases. Based on its research-centred approach, those at AOP Orphan have a profound understanding of special diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AOP OrphanAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Wilhelminenstraße 91/IIf 1160 Vienna
    Telephone
    Telephone
    +43 1 503 72 44-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aok.de/fk/nordwest/die-aok/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AOP Orphan's Sugammadex Approved In Europe
    AOP Orphan's Sugammadex Approved In Europe

    06 Jul 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    06 Jul 2023
    Share Share
    AOP Orphan's Sugammadex Amomed (Sugammadex) Receives Approval in Europe
    AOP Orphan's Sugammadex Amomed (Sugammadex) Receives Approval in Europe

    13 Jan 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    13 Jan 2023
    Share Share
    AOP Orphan's Sugammadex Amomed Receives Approval in Europe
    AOP Orphan's Sugammadex Amomed Receives Approval in Europe

    13 Jan 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    13 Jan 2023
    Share Share
    AOP Orphan Pharmaceuticals presents latest analysis on BESREMi at EHA 2021
    AOP Orphan Pharmaceuticals presents latest analysis on BESREMi at EHA 2021

    01 Jul 2021

    // PRESS RELEASE

    https://www.aoporphan.com/se_en/our-company/newsroom/aop-orphan-pharmaceuticals-presents-latest-analysis-on-besremi-r-ropeginterferon-alfa-2b-in-polycythaemia-vera-at-the-prestigious-european-hematology-association-eha-annual-meeting-2021

    PRESS RELEASE
    01 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search